drugset / Trial / NCT00171782
Hypertension and Cardiovascular Risk Factors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2 hypertension and cardiovascular risk factors.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | — | — |
| Subject | Valsartan | Small molecule | — | — |